PharmiWeb3m
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...
PharmiWeb5m
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
PharmiWeb10m
Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
PharmiWeb10m
Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line mantle cell lymphoma
AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Union (EU) for the treatment of adult patients with previously ...
PharmiWeb58m
Empowering Research: Sirius Fine Chemicals Boosts Product Credibility With Bioz AI-Driven Citation Badges
PALO ALTO, CALIFORNIA / ACCESS Newswire / March 31, 2025 / Bioz, Inc., the AI-driven citation management leader, is showcasing its new partnership with Sirius Fine Chemicals SiChem GmbH, a ...
PharmiWeb3h
Biotest AG: Delisting agreement and announced delisting tender offer
Delisting agreement and announced delisting tender offer31-March-2025 / 08:40 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS ...
PharmiWeb3h
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the ...
PharmiWeb4h
Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
Annual Report/DividendDrägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend 31.03.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb4h
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
Annual ResultsAEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025 31.03.2025 / 07:00 CET/CESTPress releaseFribourg, 31 March 2025Infracore ...
PharmiWeb4h
Biotest AG increases sales by 6% in financial year 2024
Annual ReportBiotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.  PRESS RELEASE  Biotest AG ...
PharmiWeb4h
BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRBasel, Switzerland.
PharmiWeb22h
DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump Administration Directives
"The DEA's marijuana approach is stuck in an outdated ‘war on drugs' mentality," said Duane Boise CEO of MMJ International Holdings. "While lawmakers push for medical progress, the DEA's red tape is ...